期刊文献+

Current management of liver diseases and the role of multidisciplinary approach

下载PDF
导出
摘要 Liver is an organ having extremely diversified functions,ranging from metabolic and synthetic to detoxification of harmful chemicals.The multifunctionality of the liver in principle requires the multidisciplinary and pluralistic interventions for its management.Several studies have investigated liver function,dysfunction and clinic.This editorial work discusses new ideas,challenges and perspectives of current research regarding multidisciplinary and pluralistic management of liver diseases.In one hand the discussions have carried out on the involvement of extracellular vesicles,Na^(+)/H^(+) exchangers,severe acute respiratory syndrome coronavirus 2 and Epstein–Barr virus infections,Drug-induced liver injury,sepsis,pregnancy,and food supplements in hepatic disorders.In the other hand this study has discussed hepatocellular carcinoma algorithms and new bio-chemical and imaging experiments pertaining to liver diseases.Relevant articles with an impact index value">0"from reference citation analysis,which is an open multidisciplinary citation analysis database based on artificial intelligence technology,have served for the study’s argumentation.This work may be a useful tool for the clinical practice and research in managing and investigating liver disorders.
出处 《World Journal of Hepatology》 2022年第11期1920-1930,共11页 世界肝病学杂志(英文版)(电子版)
  • 相关文献

参考文献5

二级参考文献26

  • 1Di-Yang Xie,Zheng-Gang Ren,Jian Zhou,Jia Fan,Qiang Gao.2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights[J].Hepatobiliary Surgery and Nutrition,2020,9(4):452-463. 被引量:88
  • 2Drickamer K. Clearing up glycoprotein hormones. Cell 1991;67: 1029-1032.
  • 3Kudo M, Vera DR, Trudeau WL, Stadalnik RC. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model. J Nucl Med 1991; 32: 1177-1182.
  • 4Stockert RJ. The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol Rev 1995;75: 591-609.
  • 5Trerè D, Fiume L, De Giorgi LB, Di Stefano G, Migaldi M, Derenzini M. The asialoglycoprotein receptor in human he-patocellular carcinomas: its expression on proliferating cells. Br J Cancer 1999; 81: 404-408.
  • 6Ishii H. Mechanisms of ethanol-induced impairment in asialoglycoprotein receptor expression and function. J Gastro-enterol 1998; 33: 920-921.
  • 7Burgess JB, Baenziger JU, Brown WR. Abnormal surface dis-tribution of the human asialoglycoprotein receptor in cirrho-sis. Hepatology 1992; 15: 702-706.
  • 8Pimstone NR, Stadalnik RC, Vera DR, Hutak DP, Trudeau WL. Evaluation of hepatocellular function by way of recep-tor-mediated uptake of a technetium-99m-labeled asialogly-coprotein analog. Hepatology 1994; 20: 917-923.
  • 9Tolchinsky S, Yuk MH, Ayalon M, Lodish HF, Lederkremer GZ. Membrane-bound versus secreted forms of human asialo-glycoprotein receptor subunits. Role of a juxtamembrane pentapeptide. J Biol Chem 1996; 271: 14496-14503.
  • 10Lederkremer GZ, Lodish HF. An alternatively spliced miniex-on alters the subcellular fate of the human asialoglycoprotein receptor H2 subunit. Endoplasmic reticulum retention and degradation or cell surface expression. J Biol Chem 1991; 266: 1237-1244.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部